Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -439

Accepted - Volume 4

Comment Record
Commentor Dr. Jason Theobald Date/Time 2002-11-30 09:58:00
Organization Allied Health Chiropractic Centers
Category Health Professional

Comments for FDA General
Questions
1. General Comments I fully believe the risks are too high to further jeopardize the health of children who are at virtually no risk of developing Small Pox. More research needs to be done before these randomized trials take place. The benefits here do NOT outweigh the risks, and that's the bottom line!




EC -439